nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—KIT—germ cell cancer	0.418	1	CbGaD
Dasatinib—ABCG2—Dactinomycin—germ cell cancer	0.0286	0.187	CbGbCtD
Dasatinib—CYP3A5—Ifosfamide—germ cell cancer	0.0187	0.122	CbGbCtD
Dasatinib—ABCG2—Cisplatin—germ cell cancer	0.0164	0.107	CbGbCtD
Dasatinib—ABCG2—Etoposide—germ cell cancer	0.0161	0.105	CbGbCtD
Dasatinib—ABCG2—Methotrexate—germ cell cancer	0.0106	0.0696	CbGbCtD
Dasatinib—ABCB1—Dactinomycin—germ cell cancer	0.0103	0.0673	CbGbCtD
Dasatinib—CYP3A5—Etoposide—germ cell cancer	0.00893	0.0584	CbGbCtD
Dasatinib—CYP3A4—Ifosfamide—germ cell cancer	0.00729	0.0476	CbGbCtD
Dasatinib—CYP1A2—Etoposide—germ cell cancer	0.00665	0.0435	CbGbCtD
Dasatinib—ABCB1—Vinblastine—germ cell cancer	0.00645	0.0422	CbGbCtD
Dasatinib—ABCB1—Cisplatin—germ cell cancer	0.00591	0.0387	CbGbCtD
Dasatinib—ABCB1—Etoposide—germ cell cancer	0.00581	0.038	CbGbCtD
Dasatinib—CYP3A4—Vinblastine—germ cell cancer	0.00386	0.0253	CbGbCtD
Dasatinib—ABCB1—Methotrexate—germ cell cancer	0.00384	0.0251	CbGbCtD
Dasatinib—CYP3A4—Etoposide—germ cell cancer	0.00348	0.0228	CbGbCtD
Dasatinib—ERBB3—Podofilox—Etoposide—germ cell cancer	0.00196	1	CbGdCrCtD
Dasatinib—Urethral disorder—Etoposide—germ cell cancer	0.000156	0.0011	CcSEcCtD
Dasatinib—Infection—Dactinomycin—germ cell cancer	0.000155	0.0011	CcSEcCtD
Dasatinib—Arrhythmia—Cisplatin—germ cell cancer	0.000155	0.0011	CcSEcCtD
Dasatinib—Palpitations—Ifosfamide—germ cell cancer	0.000155	0.00109	CcSEcCtD
Dasatinib—Alopecia—Cisplatin—germ cell cancer	0.000153	0.00108	CcSEcCtD
Dasatinib—Cough—Ifosfamide—germ cell cancer	0.000153	0.00108	CcSEcCtD
Dasatinib—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000152	0.00108	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000152	0.00108	CcSEcCtD
Dasatinib—Convulsion—Ifosfamide—germ cell cancer	0.000152	0.00107	CcSEcCtD
Dasatinib—Hypertension—Ifosfamide—germ cell cancer	0.000151	0.00107	CcSEcCtD
Dasatinib—Malnutrition—Cisplatin—germ cell cancer	0.000151	0.00107	CcSEcCtD
Dasatinib—Erythema—Cisplatin—germ cell cancer	0.000151	0.00107	CcSEcCtD
Dasatinib—Erythema multiforme—Etoposide—germ cell cancer	0.00015	0.00106	CcSEcCtD
Dasatinib—Dyspnoea—Bleomycin—germ cell cancer	0.000149	0.00105	CcSEcCtD
Dasatinib—Chest pain—Ifosfamide—germ cell cancer	0.000149	0.00105	CcSEcCtD
Dasatinib—Myalgia—Ifosfamide—germ cell cancer	0.000149	0.00105	CcSEcCtD
Dasatinib—Arthralgia—Ifosfamide—germ cell cancer	0.000149	0.00105	CcSEcCtD
Dasatinib—Anorexia—Dactinomycin—germ cell cancer	0.000148	0.00105	CcSEcCtD
Dasatinib—Eye disorder—Etoposide—germ cell cancer	0.000148	0.00105	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000148	0.00105	CcSEcCtD
Dasatinib—Flushing—Etoposide—germ cell cancer	0.000147	0.00104	CcSEcCtD
Dasatinib—Cardiac disorder—Etoposide—germ cell cancer	0.000147	0.00104	CcSEcCtD
Dasatinib—Discomfort—Ifosfamide—germ cell cancer	0.000147	0.00104	CcSEcCtD
Dasatinib—Hypersensitivity—Vinblastine—germ cell cancer	0.000146	0.00103	CcSEcCtD
Dasatinib—Decreased appetite—Bleomycin—germ cell cancer	0.000145	0.00103	CcSEcCtD
Dasatinib—Visual disturbance—Methotrexate—germ cell cancer	0.000145	0.00103	CcSEcCtD
Dasatinib—Muscle spasms—Cisplatin—germ cell cancer	0.000145	0.00103	CcSEcCtD
Dasatinib—Angiopathy—Etoposide—germ cell cancer	0.000144	0.00102	CcSEcCtD
Dasatinib—Confusional state—Ifosfamide—germ cell cancer	0.000144	0.00102	CcSEcCtD
Dasatinib—Immune system disorder—Etoposide—germ cell cancer	0.000143	0.00102	CcSEcCtD
Dasatinib—Mediastinal disorder—Etoposide—germ cell cancer	0.000143	0.00101	CcSEcCtD
Dasatinib—Pain—Bleomycin—germ cell cancer	0.000143	0.00101	CcSEcCtD
Dasatinib—Oedema—Ifosfamide—germ cell cancer	0.000143	0.00101	CcSEcCtD
Dasatinib—Chills—Etoposide—germ cell cancer	0.000142	0.00101	CcSEcCtD
Dasatinib—Vision blurred—Cisplatin—germ cell cancer	0.000142	0.00101	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000142	0.001	CcSEcCtD
Dasatinib—Asthenia—Vinblastine—germ cell cancer	0.000142	0.001	CcSEcCtD
Dasatinib—Infection—Ifosfamide—germ cell cancer	0.000142	0.001	CcSEcCtD
Dasatinib—Tremor—Cisplatin—germ cell cancer	0.000141	0.001	CcSEcCtD
Dasatinib—Alopecia—Etoposide—germ cell cancer	0.00014	0.000993	CcSEcCtD
Dasatinib—Cerebrovascular accident—Methotrexate—germ cell cancer	0.00014	0.000993	CcSEcCtD
Dasatinib—Nervous system disorder—Ifosfamide—germ cell cancer	0.00014	0.000991	CcSEcCtD
Dasatinib—Ill-defined disorder—Cisplatin—germ cell cancer	0.00014	0.000991	CcSEcCtD
Dasatinib—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00014	0.00099	CcSEcCtD
Dasatinib—Anaemia—Cisplatin—germ cell cancer	0.000139	0.000987	CcSEcCtD
Dasatinib—Skin disorder—Ifosfamide—germ cell cancer	0.000139	0.000982	CcSEcCtD
Dasatinib—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000138	0.000977	CcSEcCtD
Dasatinib—Feeling abnormal—Bleomycin—germ cell cancer	0.000138	0.000975	CcSEcCtD
Dasatinib—Anorexia—Ifosfamide—germ cell cancer	0.000136	0.000964	CcSEcCtD
Dasatinib—Malaise—Cisplatin—germ cell cancer	0.000136	0.000963	CcSEcCtD
Dasatinib—Decreased appetite—Dactinomycin—germ cell cancer	0.000135	0.000959	CcSEcCtD
Dasatinib—Diarrhoea—Vinblastine—germ cell cancer	0.000135	0.000958	CcSEcCtD
Dasatinib—PDGFRB—decidua—germ cell cancer	0.000135	0.000948	CbGeAlD
Dasatinib—Dysgeusia—Etoposide—germ cell cancer	0.000135	0.000958	CcSEcCtD
Dasatinib—EPHB6—spinal cord—germ cell cancer	0.000135	0.000947	CbGeAlD
Dasatinib—FMO3—endocrine gland—germ cell cancer	0.000135	0.000945	CbGeAlD
Dasatinib—CSF1R—gonad—germ cell cancer	0.000134	0.000941	CbGeAlD
Dasatinib—Fatigue—Dactinomycin—germ cell cancer	0.000134	0.000951	CcSEcCtD
Dasatinib—MAP2K5—pituitary gland—germ cell cancer	0.000134	0.000941	CbGeAlD
Dasatinib—EPHA4—cerebellum—germ cell cancer	0.000134	0.000939	CbGeAlD
Dasatinib—YES1—midbrain—germ cell cancer	0.000134	0.000938	CbGeAlD
Dasatinib—MAPK14—testis—germ cell cancer	0.000134	0.000937	CbGeAlD
Dasatinib—CSF1R—uterus—germ cell cancer	0.000133	0.000935	CbGeAlD
Dasatinib—Hypotension—Ifosfamide—germ cell cancer	0.000133	0.000945	CcSEcCtD
Dasatinib—FGR—testis—germ cell cancer	0.000133	0.000934	CbGeAlD
Dasatinib—LCK—testis—germ cell cancer	0.000133	0.000934	CbGeAlD
Dasatinib—FMO3—head—germ cell cancer	0.000133	0.000933	CbGeAlD
Dasatinib—Pain—Dactinomycin—germ cell cancer	0.000133	0.000943	CcSEcCtD
Dasatinib—EPHB4—endocrine gland—germ cell cancer	0.000133	0.000932	CbGeAlD
Dasatinib—PDGFRA—adrenal gland—germ cell cancer	0.000133	0.000932	CbGeAlD
Dasatinib—Muscle spasms—Etoposide—germ cell cancer	0.000133	0.00094	CcSEcCtD
Dasatinib—ERBB3—cerebellum—germ cell cancer	0.000133	0.00093	CbGeAlD
Dasatinib—Urticaria—Bleomycin—germ cell cancer	0.000133	0.00094	CcSEcCtD
Dasatinib—TESK1—brain—germ cell cancer	0.000132	0.000928	CbGeAlD
Dasatinib—JAK2—endocrine gland—germ cell cancer	0.000132	0.000925	CbGeAlD
Dasatinib—Body temperature increased—Bleomycin—germ cell cancer	0.000132	0.000935	CcSEcCtD
Dasatinib—MAP3K2—cerebellum—germ cell cancer	0.000131	0.000921	CbGeAlD
Dasatinib—YES1—bone marrow—germ cell cancer	0.000131	0.000919	CbGeAlD
Dasatinib—CSF1R—pituitary gland—germ cell cancer	0.000131	0.000918	CbGeAlD
Dasatinib—EPHB6—female gonad—germ cell cancer	0.000131	0.000916	CbGeAlD
Dasatinib—Dizziness—Vinblastine—germ cell cancer	0.000131	0.000926	CcSEcCtD
Dasatinib—Convulsion—Cisplatin—germ cell cancer	0.000131	0.000925	CcSEcCtD
Dasatinib—YES1—spinal cord—germ cell cancer	0.000131	0.000915	CbGeAlD
Dasatinib—EPHA2—endocrine gland—germ cell cancer	0.00013	0.000914	CbGeAlD
Dasatinib—SRC—adrenal gland—germ cell cancer	0.00013	0.000914	CbGeAlD
Dasatinib—JAK2—head—germ cell cancer	0.00013	0.000913	CbGeAlD
Dasatinib—STK36—brain—germ cell cancer	0.00013	0.000913	CbGeAlD
Dasatinib—EPHB3—brain—germ cell cancer	0.00013	0.000913	CbGeAlD
Dasatinib—FYN—endocrine gland—germ cell cancer	0.00013	0.000912	CbGeAlD
Dasatinib—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00013	0.000921	CcSEcCtD
Dasatinib—MAP2K5—medulla oblongata—germ cell cancer	0.00013	0.000908	CbGeAlD
Dasatinib—EPHA2—head—germ cell cancer	0.000129	0.000902	CbGeAlD
Dasatinib—FMO3—testis—germ cell cancer	0.000129	0.000902	CbGeAlD
Dasatinib—FYN—head—germ cell cancer	0.000129	0.000901	CbGeAlD
Dasatinib—Myalgia—Cisplatin—germ cell cancer	0.000128	0.000909	CcSEcCtD
Dasatinib—Feeling abnormal—Dactinomycin—germ cell cancer	0.000128	0.000909	CcSEcCtD
Dasatinib—Ill-defined disorder—Etoposide—germ cell cancer	0.000128	0.000908	CcSEcCtD
Dasatinib—PDGFRA—spinal cord—germ cell cancer	0.000128	0.000897	CbGeAlD
Dasatinib—TESK1—lymph node—germ cell cancer	0.000128	0.000896	CbGeAlD
Dasatinib—Anxiety—Cisplatin—germ cell cancer	0.000128	0.000906	CcSEcCtD
Dasatinib—Anaemia—Etoposide—germ cell cancer	0.000128	0.000904	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000127	0.000903	CcSEcCtD
Dasatinib—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000127	0.000902	CcSEcCtD
Dasatinib—MAP4K5—endocrine gland—germ cell cancer	0.000127	0.000892	CbGeAlD
Dasatinib—MAP3K3—endocrine gland—germ cell cancer	0.000127	0.000892	CbGeAlD
Dasatinib—Dyspnoea—Ifosfamide—germ cell cancer	0.000127	0.000901	CcSEcCtD
Dasatinib—ABL1—telencephalon—germ cell cancer	0.000127	0.000891	CbGeAlD
Dasatinib—Somnolence—Ifosfamide—germ cell cancer	0.000127	0.000899	CcSEcCtD
Dasatinib—Discomfort—Cisplatin—germ cell cancer	0.000127	0.000898	CcSEcCtD
Dasatinib—EPHB4—testis—germ cell cancer	0.000127	0.000889	CbGeAlD
Dasatinib—CSF1R—medulla oblongata—germ cell cancer	0.000126	0.000886	CbGeAlD
Dasatinib—YES1—female gonad—germ cell cancer	0.000126	0.000885	CbGeAlD
Dasatinib—LIMK2—brain—germ cell cancer	0.000126	0.000883	CbGeAlD
Dasatinib—JAK2—testis—germ cell cancer	0.000126	0.000882	CbGeAlD
Dasatinib—STK36—lymph node—germ cell cancer	0.000126	0.000882	CbGeAlD
Dasatinib—EPHB3—lymph node—germ cell cancer	0.000126	0.000882	CbGeAlD
Dasatinib—Vomiting—Vinblastine—germ cell cancer	0.000126	0.00089	CcSEcCtD
Dasatinib—MAP3K3—head—germ cell cancer	0.000126	0.00088	CbGeAlD
Dasatinib—MAP4K5—head—germ cell cancer	0.000126	0.00088	CbGeAlD
Dasatinib—SRC—spinal cord—germ cell cancer	0.000126	0.00088	CbGeAlD
Dasatinib—Malaise—Etoposide—germ cell cancer	0.000125	0.000882	CcSEcCtD
Dasatinib—EPHA2—testis—germ cell cancer	0.000124	0.000872	CbGeAlD
Dasatinib—FYN—testis—germ cell cancer	0.000124	0.00087	CbGeAlD
Dasatinib—Breast disorder—Methotrexate—germ cell cancer	0.000124	0.000879	CcSEcCtD
Dasatinib—Vertigo—Etoposide—germ cell cancer	0.000124	0.000879	CcSEcCtD
Dasatinib—Decreased appetite—Ifosfamide—germ cell cancer	0.000124	0.000879	CcSEcCtD
Dasatinib—PDGFRA—female gonad—germ cell cancer	0.000124	0.000869	CbGeAlD
Dasatinib—Headache—Vinblastine—germ cell cancer	0.000124	0.000877	CcSEcCtD
Dasatinib—MAPK14—cerebellum—germ cell cancer	0.000124	0.000866	CbGeAlD
Dasatinib—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000123	0.000873	CcSEcCtD
Dasatinib—Abdominal pain—Dactinomycin—germ cell cancer	0.000123	0.000872	CcSEcCtD
Dasatinib—Body temperature increased—Dactinomycin—germ cell cancer	0.000123	0.000872	CcSEcCtD
Dasatinib—Fatigue—Ifosfamide—germ cell cancer	0.000123	0.000871	CcSEcCtD
Dasatinib—Oedema—Cisplatin—germ cell cancer	0.000123	0.000871	CcSEcCtD
Dasatinib—Hypersensitivity—Bleomycin—germ cell cancer	0.000123	0.000871	CcSEcCtD
Dasatinib—Infection—Cisplatin—germ cell cancer	0.000122	0.000866	CcSEcCtD
Dasatinib—STK35—brain—germ cell cancer	0.000122	0.000856	CbGeAlD
Dasatinib—Constipation—Ifosfamide—germ cell cancer	0.000122	0.000864	CcSEcCtD
Dasatinib—Pain—Ifosfamide—germ cell cancer	0.000122	0.000864	CcSEcCtD
Dasatinib—KIT—gonad—germ cell cancer	0.000122	0.000855	CbGeAlD
Dasatinib—LIMK2—lymph node—germ cell cancer	0.000122	0.000853	CbGeAlD
Dasatinib—SRC—female gonad—germ cell cancer	0.000122	0.000852	CbGeAlD
Dasatinib—ABL1—skin of body—germ cell cancer	0.000121	0.000851	CbGeAlD
Dasatinib—Loss of consciousness—Etoposide—germ cell cancer	0.000121	0.00086	CcSEcCtD
Dasatinib—MAP4K5—testis—germ cell cancer	0.000121	0.00085	CbGeAlD
Dasatinib—MAP3K3—testis—germ cell cancer	0.000121	0.00085	CbGeAlD
Dasatinib—CSK—brain—germ cell cancer	0.000121	0.00085	CbGeAlD
Dasatinib—KIT—uterus—germ cell cancer	0.000121	0.000849	CbGeAlD
Dasatinib—Nervous system disorder—Cisplatin—germ cell cancer	0.000121	0.000855	CcSEcCtD
Dasatinib—ABL1—decidua—germ cell cancer	0.000121	0.000845	CbGeAlD
Dasatinib—Cough—Etoposide—germ cell cancer	0.000121	0.000854	CcSEcCtD
Dasatinib—Thrombocytopenia—Cisplatin—germ cell cancer	0.00012	0.000853	CcSEcCtD
Dasatinib—Tachycardia—Cisplatin—germ cell cancer	0.00012	0.000851	CcSEcCtD
Dasatinib—EPHB6—head—germ cell cancer	0.00012	0.000841	CbGeAlD
Dasatinib—MAP2K5—adrenal gland—germ cell cancer	0.00012	0.00084	CbGeAlD
Dasatinib—Asthenia—Bleomycin—germ cell cancer	0.00012	0.000849	CcSEcCtD
Dasatinib—HCK—brain—germ cell cancer	0.00012	0.000839	CbGeAlD
Dasatinib—Convulsion—Etoposide—germ cell cancer	0.00012	0.000848	CcSEcCtD
Dasatinib—Skin disorder—Cisplatin—germ cell cancer	0.00012	0.000846	CcSEcCtD
Dasatinib—Hypertension—Etoposide—germ cell cancer	0.000119	0.000845	CcSEcCtD
Dasatinib—PDGFRB—gonad—germ cell cancer	0.000119	0.000835	CbGeAlD
Dasatinib—ABL2—brain—germ cell cancer	0.000119	0.000834	CbGeAlD
Dasatinib—KIT—pituitary gland—germ cell cancer	0.000119	0.000834	CbGeAlD
Dasatinib—Hyperhidrosis—Cisplatin—germ cell cancer	0.000119	0.000842	CcSEcCtD
Dasatinib—Asthma—Methotrexate—germ cell cancer	0.000119	0.000841	CcSEcCtD
Dasatinib—MAP2K5—midbrain—germ cell cancer	0.000118	0.00083	CbGeAlD
Dasatinib—PDGFRB—uterus—germ cell cancer	0.000118	0.000829	CbGeAlD
Dasatinib—CYP1B1—eye—germ cell cancer	0.000118	0.000828	CbGeAlD
Dasatinib—Pruritus—Bleomycin—germ cell cancer	0.000118	0.000837	CcSEcCtD
Dasatinib—STK35—lymph node—germ cell cancer	0.000118	0.000827	CbGeAlD
Dasatinib—Feeling abnormal—Ifosfamide—germ cell cancer	0.000118	0.000833	CcSEcCtD
Dasatinib—Chest pain—Etoposide—germ cell cancer	0.000118	0.000833	CcSEcCtD
Dasatinib—YES1—endocrine gland—germ cell cancer	0.000118	0.000824	CbGeAlD
Dasatinib—Nausea—Vinblastine—germ cell cancer	0.000117	0.000832	CcSEcCtD
Dasatinib—Anorexia—Cisplatin—germ cell cancer	0.000117	0.000831	CcSEcCtD
Dasatinib—CSK—lymph node—germ cell cancer	0.000117	0.000821	CbGeAlD
Dasatinib—EPHB4—cerebellum—germ cell cancer	0.000117	0.000821	CbGeAlD
Dasatinib—CSF1R—adrenal gland—germ cell cancer	0.000117	0.00082	CbGeAlD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000117	0.000827	CcSEcCtD
Dasatinib—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000117	0.000827	CcSEcCtD
Dasatinib—Pancreatitis—Methotrexate—germ cell cancer	0.000116	0.000824	CcSEcCtD
Dasatinib—JAK2—cerebellum—germ cell cancer	0.000116	0.000815	CbGeAlD
Dasatinib—PDGFRB—pituitary gland—germ cell cancer	0.000116	0.000814	CbGeAlD
Dasatinib—Discomfort—Etoposide—germ cell cancer	0.000116	0.000823	CcSEcCtD
Dasatinib—YES1—head—germ cell cancer	0.000116	0.000813	CbGeAlD
Dasatinib—EPHB6—testis—germ cell cancer	0.000116	0.000813	CbGeAlD
Dasatinib—HCK—lymph node—germ cell cancer	0.000116	0.000811	CbGeAlD
Dasatinib—CSF1R—midbrain—germ cell cancer	0.000116	0.00081	CbGeAlD
Dasatinib—MAP2K5—spinal cord—germ cell cancer	0.000116	0.00081	CbGeAlD
Dasatinib—PDGFRA—endocrine gland—germ cell cancer	0.000115	0.000808	CbGeAlD
Dasatinib—ABL2—lymph node—germ cell cancer	0.000115	0.000806	CbGeAlD
Dasatinib—Hypotension—Cisplatin—germ cell cancer	0.000115	0.000814	CcSEcCtD
Dasatinib—KIT—medulla oblongata—germ cell cancer	0.000115	0.000804	CbGeAlD
Dasatinib—Hypersensitivity—Dactinomycin—germ cell cancer	0.000115	0.000813	CcSEcCtD
Dasatinib—FYN—cerebellum—germ cell cancer	0.000115	0.000804	CbGeAlD
Dasatinib—PDGFRA—head—germ cell cancer	0.000114	0.000798	CbGeAlD
Dasatinib—Confusional state—Etoposide—germ cell cancer	0.000114	0.000805	CcSEcCtD
Dasatinib—Urticaria—Ifosfamide—germ cell cancer	0.000113	0.000803	CcSEcCtD
Dasatinib—CSF1R—bone marrow—germ cell cancer	0.000113	0.000793	CbGeAlD
Dasatinib—SRC—endocrine gland—germ cell cancer	0.000113	0.000792	CbGeAlD
Dasatinib—Abdominal pain—Ifosfamide—germ cell cancer	0.000113	0.000799	CcSEcCtD
Dasatinib—Body temperature increased—Ifosfamide—germ cell cancer	0.000113	0.000799	CcSEcCtD
Dasatinib—Pancytopenia—Methotrexate—germ cell cancer	0.000113	0.000799	CcSEcCtD
Dasatinib—CSF1R—spinal cord—germ cell cancer	0.000113	0.00079	CbGeAlD
Dasatinib—RIPK2—brain—germ cell cancer	0.000113	0.000789	CbGeAlD
Dasatinib—PDGFRB—medulla oblongata—germ cell cancer	0.000112	0.000786	CbGeAlD
Dasatinib—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000112	0.000794	CcSEcCtD
Dasatinib—MAP4K5—cerebellum—germ cell cancer	0.000112	0.000785	CbGeAlD
Dasatinib—MAP3K3—cerebellum—germ cell cancer	0.000112	0.000785	CbGeAlD
Dasatinib—YES1—testis—germ cell cancer	0.000112	0.000785	CbGeAlD
Dasatinib—Infection—Etoposide—germ cell cancer	0.000112	0.000793	CcSEcCtD
Dasatinib—MAP2K5—female gonad—germ cell cancer	0.000112	0.000784	CbGeAlD
Dasatinib—Asthenia—Dactinomycin—germ cell cancer	0.000112	0.000791	CcSEcCtD
Dasatinib—SRC—head—germ cell cancer	0.000112	0.000782	CbGeAlD
Dasatinib—Neutropenia—Methotrexate—germ cell cancer	0.000111	0.000786	CcSEcCtD
Dasatinib—Thrombocytopenia—Etoposide—germ cell cancer	0.00011	0.000782	CcSEcCtD
Dasatinib—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.00011	0.000782	CcSEcCtD
Dasatinib—Tachycardia—Etoposide—germ cell cancer	0.00011	0.000779	CcSEcCtD
Dasatinib—PDGFRA—testis—germ cell cancer	0.00011	0.00077	CbGeAlD
Dasatinib—SIK1—brain—germ cell cancer	0.00011	0.00077	CbGeAlD
Dasatinib—Dyspnoea—Cisplatin—germ cell cancer	0.00011	0.000777	CcSEcCtD
Dasatinib—Skin disorder—Etoposide—germ cell cancer	0.000109	0.000775	CcSEcCtD
Dasatinib—CSF1R—female gonad—germ cell cancer	0.000109	0.000765	CbGeAlD
Dasatinib—Hyperhidrosis—Etoposide—germ cell cancer	0.000109	0.000772	CcSEcCtD
Dasatinib—EPHA4—brain—germ cell cancer	0.000109	0.000763	CbGeAlD
Dasatinib—RIPK2—lymph node—germ cell cancer	0.000109	0.000762	CbGeAlD
Dasatinib—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000108	0.000768	CcSEcCtD
Dasatinib—SRC—testis—germ cell cancer	0.000108	0.000756	CbGeAlD
Dasatinib—ERBB3—brain—germ cell cancer	0.000108	0.000755	CbGeAlD
Dasatinib—CYP1B1—telencephalon—germ cell cancer	0.000108	0.000755	CbGeAlD
Dasatinib—Anorexia—Etoposide—germ cell cancer	0.000107	0.000761	CcSEcCtD
Dasatinib—EPHB6—cerebellum—germ cell cancer	0.000107	0.000751	CbGeAlD
Dasatinib—Decreased appetite—Cisplatin—germ cell cancer	0.000107	0.000758	CcSEcCtD
Dasatinib—MAP3K2—brain—germ cell cancer	0.000107	0.000748	CbGeAlD
Dasatinib—Diarrhoea—Dactinomycin—germ cell cancer	0.000107	0.000755	CcSEcCtD
Dasatinib—Pneumonia—Methotrexate—germ cell cancer	0.000106	0.000754	CcSEcCtD
Dasatinib—KIT—adrenal gland—germ cell cancer	0.000106	0.000745	CbGeAlD
Dasatinib—SIK1—lymph node—germ cell cancer	0.000106	0.000744	CbGeAlD
Dasatinib—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000106	0.000752	CcSEcCtD
Dasatinib—Vomiting—Bleomycin—germ cell cancer	0.000106	0.000752	CcSEcCtD
Dasatinib—ABL1—gonad—germ cell cancer	0.000106	0.000744	CbGeAlD
Dasatinib—Infestation—Methotrexate—germ cell cancer	0.000106	0.00075	CcSEcCtD
Dasatinib—Infestation NOS—Methotrexate—germ cell cancer	0.000106	0.00075	CcSEcCtD
Dasatinib—ABL1—uterus—germ cell cancer	0.000105	0.000739	CbGeAlD
Dasatinib—Hypotension—Etoposide—germ cell cancer	0.000105	0.000746	CcSEcCtD
Dasatinib—Rash—Bleomycin—germ cell cancer	0.000105	0.000746	CcSEcCtD
Dasatinib—Pain—Cisplatin—germ cell cancer	0.000105	0.000745	CcSEcCtD
Dasatinib—Dermatitis—Bleomycin—germ cell cancer	0.000105	0.000745	CcSEcCtD
Dasatinib—EPHA4—lymph node—germ cell cancer	0.000105	0.000737	CbGeAlD
Dasatinib—Hypersensitivity—Ifosfamide—germ cell cancer	0.000105	0.000745	CcSEcCtD
Dasatinib—KIT—midbrain—germ cell cancer	0.000105	0.000735	CbGeAlD
Dasatinib—ERBB3—lymph node—germ cell cancer	0.000104	0.00073	CbGeAlD
Dasatinib—Renal failure—Methotrexate—germ cell cancer	0.000104	0.000737	CcSEcCtD
Dasatinib—MAP2K5—endocrine gland—germ cell cancer	0.000104	0.000729	CbGeAlD
Dasatinib—PDGFRB—adrenal gland—germ cell cancer	0.000104	0.000727	CbGeAlD
Dasatinib—ABL1—pituitary gland—germ cell cancer	0.000104	0.000726	CbGeAlD
Dasatinib—YES1—cerebellum—germ cell cancer	0.000104	0.000725	CbGeAlD
Dasatinib—Stomatitis—Methotrexate—germ cell cancer	0.000103	0.000731	CcSEcCtD
Dasatinib—MAP3K2—lymph node—germ cell cancer	0.000103	0.000723	CbGeAlD
Dasatinib—Conjunctivitis—Methotrexate—germ cell cancer	0.000103	0.000729	CcSEcCtD
Dasatinib—KIT—bone marrow—germ cell cancer	0.000103	0.00072	CbGeAlD
Dasatinib—CYP1B1—skin of body—germ cell cancer	0.000103	0.00072	CbGeAlD
Dasatinib—MAP2K5—head—germ cell cancer	0.000103	0.000719	CbGeAlD
Dasatinib—PDGFRB—midbrain—germ cell cancer	0.000102	0.000718	CbGeAlD
Dasatinib—Asthenia—Ifosfamide—germ cell cancer	0.000102	0.000725	CcSEcCtD
Dasatinib—KIT—spinal cord—germ cell cancer	0.000102	0.000717	CbGeAlD
Dasatinib—ABCG2—trigeminal ganglion—germ cell cancer	0.000102	0.000716	CbGeAlD
Dasatinib—CYP1B1—decidua—germ cell cancer	0.000102	0.000715	CbGeAlD
Dasatinib—PDGFRA—cerebellum—germ cell cancer	0.000102	0.000712	CbGeAlD
Dasatinib—CSF1R—endocrine gland—germ cell cancer	0.000102	0.000711	CbGeAlD
Dasatinib—Feeling abnormal—Cisplatin—germ cell cancer	0.000101	0.000718	CcSEcCtD
Dasatinib—Pruritus—Ifosfamide—germ cell cancer	0.000101	0.000715	CcSEcCtD
Dasatinib—Haematuria—Methotrexate—germ cell cancer	0.000101	0.000715	CcSEcCtD
Dasatinib—Dyspnoea—Etoposide—germ cell cancer	0.0001	0.000712	CcSEcCtD
Dasatinib—PDGFRB—bone marrow—germ cell cancer	0.0001	0.000704	CbGeAlD
Dasatinib—MAPK14—brain—germ cell cancer	0.0001	0.000703	CbGeAlD
Dasatinib—Somnolence—Etoposide—germ cell cancer	0.0001	0.00071	CcSEcCtD
Dasatinib—CSF1R—head—germ cell cancer	0.0001	0.000702	CbGeAlD
Dasatinib—Hepatobiliary disease—Methotrexate—germ cell cancer	0.0001	0.000709	CcSEcCtD
Dasatinib—PDGFRB—spinal cord—germ cell cancer	0.0001	0.000701	CbGeAlD
Dasatinib—ABL1—medulla oblongata—germ cell cancer	9.99e-05	0.0007	CbGeAlD
Dasatinib—FGR—brain—germ cell cancer	9.99e-05	0.0007	CbGeAlD
Dasatinib—Epistaxis—Methotrexate—germ cell cancer	9.99e-05	0.000707	CcSEcCtD
Dasatinib—SRC—cerebellum—germ cell cancer	9.96e-05	0.000698	CbGeAlD
Dasatinib—Nausea—Bleomycin—germ cell cancer	9.92e-05	0.000703	CcSEcCtD
Dasatinib—MAP2K5—testis—germ cell cancer	9.92e-05	0.000695	CbGeAlD
Dasatinib—KIT—female gonad—germ cell cancer	9.91e-05	0.000694	CbGeAlD
Dasatinib—Vomiting—Dactinomycin—germ cell cancer	9.9e-05	0.000701	CcSEcCtD
Dasatinib—Rash—Dactinomycin—germ cell cancer	9.82e-05	0.000696	CcSEcCtD
Dasatinib—Decreased appetite—Etoposide—germ cell cancer	9.8e-05	0.000694	CcSEcCtD
Dasatinib—Diarrhoea—Ifosfamide—germ cell cancer	9.77e-05	0.000692	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Etoposide—germ cell cancer	9.73e-05	0.000689	CcSEcCtD
Dasatinib—Body temperature increased—Cisplatin—germ cell cancer	9.73e-05	0.000689	CcSEcCtD
Dasatinib—Fatigue—Etoposide—germ cell cancer	9.72e-05	0.000688	CcSEcCtD
Dasatinib—MAPK14—lymph node—germ cell cancer	9.7e-05	0.000679	CbGeAlD
Dasatinib—CSF1R—testis—germ cell cancer	9.68e-05	0.000678	CbGeAlD
Dasatinib—PDGFRB—female gonad—germ cell cancer	9.68e-05	0.000678	CbGeAlD
Dasatinib—FGR—lymph node—germ cell cancer	9.66e-05	0.000677	CbGeAlD
Dasatinib—LCK—lymph node—germ cell cancer	9.66e-05	0.000677	CbGeAlD
Dasatinib—FMO3—brain—germ cell cancer	9.65e-05	0.000676	CbGeAlD
Dasatinib—Constipation—Etoposide—germ cell cancer	9.64e-05	0.000683	CcSEcCtD
Dasatinib—Pain—Etoposide—germ cell cancer	9.64e-05	0.000683	CcSEcCtD
Dasatinib—Haemoglobin—Methotrexate—germ cell cancer	9.55e-05	0.000677	CcSEcCtD
Dasatinib—EPHB4—brain—germ cell cancer	9.51e-05	0.000667	CbGeAlD
Dasatinib—Haemorrhage—Methotrexate—germ cell cancer	9.5e-05	0.000673	CcSEcCtD
Dasatinib—Hepatitis—Methotrexate—germ cell cancer	9.5e-05	0.000673	CcSEcCtD
Dasatinib—JAK2—brain—germ cell cancer	9.45e-05	0.000662	CbGeAlD
Dasatinib—Dizziness—Ifosfamide—germ cell cancer	9.44e-05	0.000668	CcSEcCtD
Dasatinib—Urinary tract disorder—Methotrexate—germ cell cancer	9.39e-05	0.000665	CcSEcCtD
Dasatinib—EPHA2—brain—germ cell cancer	9.33e-05	0.000654	CbGeAlD
Dasatinib—FMO3—lymph node—germ cell cancer	9.33e-05	0.000654	CbGeAlD
Dasatinib—FYN—brain—germ cell cancer	9.32e-05	0.000653	CbGeAlD
Dasatinib—Urethral disorder—Methotrexate—germ cell cancer	9.32e-05	0.00066	CcSEcCtD
Dasatinib—Feeling abnormal—Etoposide—germ cell cancer	9.29e-05	0.000658	CcSEcCtD
Dasatinib—ABL1—adrenal gland—germ cell cancer	9.25e-05	0.000648	CbGeAlD
Dasatinib—Nausea—Dactinomycin—germ cell cancer	9.25e-05	0.000655	CcSEcCtD
Dasatinib—Gastrointestinal pain—Etoposide—germ cell cancer	9.22e-05	0.000653	CcSEcCtD
Dasatinib—KIT—endocrine gland—germ cell cancer	9.22e-05	0.000646	CbGeAlD
Dasatinib—EPHB4—lymph node—germ cell cancer	9.19e-05	0.000644	CbGeAlD
Dasatinib—MAP2K5—cerebellum—germ cell cancer	9.16e-05	0.000642	CbGeAlD
Dasatinib—Visual impairment—Methotrexate—germ cell cancer	9.16e-05	0.000649	CcSEcCtD
Dasatinib—ABL1—midbrain—germ cell cancer	9.14e-05	0.00064	CbGeAlD
Dasatinib—JAK2—lymph node—germ cell cancer	9.13e-05	0.00064	CbGeAlD
Dasatinib—MAP4K5—brain—germ cell cancer	9.1e-05	0.000638	CbGeAlD
Dasatinib—MAP3K3—brain—germ cell cancer	9.1e-05	0.000638	CbGeAlD
Dasatinib—KIT—head—germ cell cancer	9.1e-05	0.000638	CbGeAlD
Dasatinib—Vomiting—Ifosfamide—germ cell cancer	9.07e-05	0.000643	CcSEcCtD
Dasatinib—Hypersensitivity—Cisplatin—germ cell cancer	9.07e-05	0.000642	CcSEcCtD
Dasatinib—EPHA2—lymph node—germ cell cancer	9.02e-05	0.000632	CbGeAlD
Dasatinib—PDGFRB—endocrine gland—germ cell cancer	9e-05	0.000631	CbGeAlD
Dasatinib—FYN—lymph node—germ cell cancer	9e-05	0.000631	CbGeAlD
Dasatinib—Rash—Ifosfamide—germ cell cancer	9e-05	0.000637	CcSEcCtD
Dasatinib—CYP1B1—gonad—germ cell cancer	8.99e-05	0.00063	CbGeAlD
Dasatinib—Dermatitis—Ifosfamide—germ cell cancer	8.99e-05	0.000637	CcSEcCtD
Dasatinib—Erythema multiforme—Methotrexate—germ cell cancer	8.99e-05	0.000636	CcSEcCtD
Dasatinib—Urticaria—Etoposide—germ cell cancer	8.95e-05	0.000634	CcSEcCtD
Dasatinib—ABL1—bone marrow—germ cell cancer	8.95e-05	0.000627	CbGeAlD
Dasatinib—CSF1R—cerebellum—germ cell cancer	8.94e-05	0.000626	CbGeAlD
Dasatinib—CYP1B1—uterus—germ cell cancer	8.93e-05	0.000626	CbGeAlD
Dasatinib—ABL1—spinal cord—germ cell cancer	8.91e-05	0.000624	CbGeAlD
Dasatinib—Body temperature increased—Etoposide—germ cell cancer	8.91e-05	0.000631	CcSEcCtD
Dasatinib—Abdominal pain—Etoposide—germ cell cancer	8.91e-05	0.000631	CcSEcCtD
Dasatinib—PDGFRB—head—germ cell cancer	8.89e-05	0.000623	CbGeAlD
Dasatinib—Eye disorder—Methotrexate—germ cell cancer	8.88e-05	0.000629	CcSEcCtD
Dasatinib—Tinnitus—Methotrexate—germ cell cancer	8.86e-05	0.000628	CcSEcCtD
Dasatinib—Asthenia—Cisplatin—germ cell cancer	8.83e-05	0.000625	CcSEcCtD
Dasatinib—Cardiac disorder—Methotrexate—germ cell cancer	8.82e-05	0.000625	CcSEcCtD
Dasatinib—MAP3K3—lymph node—germ cell cancer	8.8e-05	0.000616	CbGeAlD
Dasatinib—MAP4K5—lymph node—germ cell cancer	8.8e-05	0.000616	CbGeAlD
Dasatinib—KIT—testis—germ cell cancer	8.79e-05	0.000616	CbGeAlD
Dasatinib—CYP1B1—pituitary gland—germ cell cancer	8.77e-05	0.000615	CbGeAlD
Dasatinib—EPHB6—brain—germ cell cancer	8.7e-05	0.00061	CbGeAlD
Dasatinib—ABL1—female gonad—germ cell cancer	8.63e-05	0.000605	CbGeAlD
Dasatinib—Angiopathy—Methotrexate—germ cell cancer	8.62e-05	0.000611	CcSEcCtD
Dasatinib—PDGFRB—testis—germ cell cancer	8.59e-05	0.000602	CbGeAlD
Dasatinib—Immune system disorder—Methotrexate—germ cell cancer	8.58e-05	0.000608	CcSEcCtD
Dasatinib—Mediastinal disorder—Methotrexate—germ cell cancer	8.57e-05	0.000607	CcSEcCtD
Dasatinib—Chills—Methotrexate—germ cell cancer	8.53e-05	0.000604	CcSEcCtD
Dasatinib—Nausea—Ifosfamide—germ cell cancer	8.48e-05	0.0006	CcSEcCtD
Dasatinib—Diarrhoea—Cisplatin—germ cell cancer	8.42e-05	0.000596	CcSEcCtD
Dasatinib—YES1—brain—germ cell cancer	8.41e-05	0.000589	CbGeAlD
Dasatinib—EPHB6—lymph node—germ cell cancer	8.41e-05	0.000589	CbGeAlD
Dasatinib—Alopecia—Methotrexate—germ cell cancer	8.4e-05	0.000595	CcSEcCtD
Dasatinib—Mental disorder—Methotrexate—germ cell cancer	8.33e-05	0.00059	CcSEcCtD
Dasatinib—Hypersensitivity—Etoposide—germ cell cancer	8.3e-05	0.000588	CcSEcCtD
Dasatinib—Malnutrition—Methotrexate—germ cell cancer	8.27e-05	0.000586	CcSEcCtD
Dasatinib—Erythema—Methotrexate—germ cell cancer	8.27e-05	0.000586	CcSEcCtD
Dasatinib—PDGFRA—brain—germ cell cancer	8.25e-05	0.000578	CbGeAlD
Dasatinib—ABCB1—blood vessel—germ cell cancer	8.15e-05	0.000571	CbGeAlD
Dasatinib—YES1—lymph node—germ cell cancer	8.12e-05	0.000569	CbGeAlD
Dasatinib—KIT—cerebellum—germ cell cancer	8.12e-05	0.000569	CbGeAlD
Dasatinib—Dysgeusia—Methotrexate—germ cell cancer	8.1e-05	0.000574	CcSEcCtD
Dasatinib—SRC—brain—germ cell cancer	8.09e-05	0.000567	CbGeAlD
Dasatinib—Asthenia—Etoposide—germ cell cancer	8.09e-05	0.000573	CcSEcCtD
Dasatinib—ABL1—endocrine gland—germ cell cancer	8.02e-05	0.000562	CbGeAlD
Dasatinib—ABCG2—telencephalon—germ cell cancer	8.02e-05	0.000562	CbGeAlD
Dasatinib—Pruritus—Etoposide—germ cell cancer	7.98e-05	0.000565	CcSEcCtD
Dasatinib—PDGFRA—lymph node—germ cell cancer	7.97e-05	0.000558	CbGeAlD
Dasatinib—PDGFRB—cerebellum—germ cell cancer	7.93e-05	0.000556	CbGeAlD
Dasatinib—ABL1—head—germ cell cancer	7.92e-05	0.000555	CbGeAlD
Dasatinib—CYP1B1—adrenal gland—germ cell cancer	7.84e-05	0.000549	CbGeAlD
Dasatinib—Vomiting—Cisplatin—germ cell cancer	7.82e-05	0.000554	CcSEcCtD
Dasatinib—SRC—lymph node—germ cell cancer	7.82e-05	0.000548	CbGeAlD
Dasatinib—Vision blurred—Methotrexate—germ cell cancer	7.8e-05	0.000552	CcSEcCtD
Dasatinib—Rash—Cisplatin—germ cell cancer	7.76e-05	0.000549	CcSEcCtD
Dasatinib—Dermatitis—Cisplatin—germ cell cancer	7.75e-05	0.000549	CcSEcCtD
Dasatinib—Diarrhoea—Etoposide—germ cell cancer	7.71e-05	0.000546	CcSEcCtD
Dasatinib—Ill-defined disorder—Methotrexate—germ cell cancer	7.68e-05	0.000544	CcSEcCtD
Dasatinib—ABL1—testis—germ cell cancer	7.65e-05	0.000536	CbGeAlD
Dasatinib—Anaemia—Methotrexate—germ cell cancer	7.65e-05	0.000542	CcSEcCtD
Dasatinib—ABCG2—decidua—germ cell cancer	7.6e-05	0.000533	CbGeAlD
Dasatinib—Malaise—Methotrexate—germ cell cancer	7.46e-05	0.000528	CcSEcCtD
Dasatinib—Dizziness—Etoposide—germ cell cancer	7.45e-05	0.000528	CcSEcCtD
Dasatinib—MAP2K5—brain—germ cell cancer	7.44e-05	0.000521	CbGeAlD
Dasatinib—Vertigo—Methotrexate—germ cell cancer	7.43e-05	0.000526	CcSEcCtD
Dasatinib—Nausea—Cisplatin—germ cell cancer	7.31e-05	0.000518	CcSEcCtD
Dasatinib—CYP1B1—female gonad—germ cell cancer	7.31e-05	0.000512	CbGeAlD
Dasatinib—CYP1A1—skin of body—germ cell cancer	7.27e-05	0.000509	CbGeAlD
Dasatinib—CSF1R—brain—germ cell cancer	7.26e-05	0.000509	CbGeAlD
Dasatinib—Cough—Methotrexate—germ cell cancer	7.22e-05	0.000511	CcSEcCtD
Dasatinib—MAP2K5—lymph node—germ cell cancer	7.19e-05	0.000504	CbGeAlD
Dasatinib—Convulsion—Methotrexate—germ cell cancer	7.17e-05	0.000508	CcSEcCtD
Dasatinib—Vomiting—Etoposide—germ cell cancer	7.17e-05	0.000508	CcSEcCtD
Dasatinib—Rash—Etoposide—germ cell cancer	7.11e-05	0.000503	CcSEcCtD
Dasatinib—Dermatitis—Etoposide—germ cell cancer	7.1e-05	0.000503	CcSEcCtD
Dasatinib—ABL1—cerebellum—germ cell cancer	7.07e-05	0.000495	CbGeAlD
Dasatinib—Headache—Etoposide—germ cell cancer	7.06e-05	0.0005	CcSEcCtD
Dasatinib—Arthralgia—Methotrexate—germ cell cancer	7.04e-05	0.000499	CcSEcCtD
Dasatinib—Chest pain—Methotrexate—germ cell cancer	7.04e-05	0.000499	CcSEcCtD
Dasatinib—Myalgia—Methotrexate—germ cell cancer	7.04e-05	0.000499	CcSEcCtD
Dasatinib—CSF1R—lymph node—germ cell cancer	7.02e-05	0.000492	CbGeAlD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	6.99e-05	0.000495	CcSEcCtD
Dasatinib—Discomfort—Methotrexate—germ cell cancer	6.96e-05	0.000493	CcSEcCtD
Dasatinib—Confusional state—Methotrexate—germ cell cancer	6.81e-05	0.000482	CcSEcCtD
Dasatinib—CYP1B1—endocrine gland—germ cell cancer	6.79e-05	0.000476	CbGeAlD
Dasatinib—CYP1B1—head—germ cell cancer	6.71e-05	0.00047	CbGeAlD
Dasatinib—Infection—Methotrexate—germ cell cancer	6.71e-05	0.000475	CcSEcCtD
Dasatinib—Nausea—Etoposide—germ cell cancer	6.7e-05	0.000474	CcSEcCtD
Dasatinib—ABCG2—uterus—germ cell cancer	6.65e-05	0.000466	CbGeAlD
Dasatinib—Nervous system disorder—Methotrexate—germ cell cancer	6.62e-05	0.000469	CcSEcCtD
Dasatinib—Thrombocytopenia—Methotrexate—germ cell cancer	6.61e-05	0.000468	CcSEcCtD
Dasatinib—KIT—brain—germ cell cancer	6.59e-05	0.000462	CbGeAlD
Dasatinib—Skin disorder—Methotrexate—germ cell cancer	6.56e-05	0.000464	CcSEcCtD
Dasatinib—ABCG2—pituitary gland—germ cell cancer	6.53e-05	0.000458	CbGeAlD
Dasatinib—Hyperhidrosis—Methotrexate—germ cell cancer	6.53e-05	0.000462	CcSEcCtD
Dasatinib—CYP1B1—testis—germ cell cancer	6.48e-05	0.000454	CbGeAlD
Dasatinib—PDGFRB—brain—germ cell cancer	6.44e-05	0.000451	CbGeAlD
Dasatinib—Anorexia—Methotrexate—germ cell cancer	6.44e-05	0.000456	CcSEcCtD
Dasatinib—KIT—lymph node—germ cell cancer	6.37e-05	0.000446	CbGeAlD
Dasatinib—CYP1A1—uterus—germ cell cancer	6.31e-05	0.000442	CbGeAlD
Dasatinib—Hypotension—Methotrexate—germ cell cancer	6.31e-05	0.000447	CcSEcCtD
Dasatinib—ABCG2—medulla oblongata—germ cell cancer	6.3e-05	0.000442	CbGeAlD
Dasatinib—PDGFRB—lymph node—germ cell cancer	6.22e-05	0.000436	CbGeAlD
Dasatinib—Musculoskeletal discomfort—Methotrexate—germ cell cancer	6.15e-05	0.000436	CcSEcCtD
Dasatinib—Insomnia—Methotrexate—germ cell cancer	6.11e-05	0.000433	CcSEcCtD
Dasatinib—Dyspnoea—Methotrexate—germ cell cancer	6.02e-05	0.000426	CcSEcCtD
Dasatinib—Somnolence—Methotrexate—germ cell cancer	6e-05	0.000425	CcSEcCtD
Dasatinib—CYP1B1—cerebellum—germ cell cancer	5.98e-05	0.000419	CbGeAlD
Dasatinib—Dyspepsia—Methotrexate—germ cell cancer	5.94e-05	0.000421	CcSEcCtD
Dasatinib—Decreased appetite—Methotrexate—germ cell cancer	5.87e-05	0.000416	CcSEcCtD
Dasatinib—ABCG2—adrenal gland—germ cell cancer	5.83e-05	0.000409	CbGeAlD
Dasatinib—Gastrointestinal disorder—Methotrexate—germ cell cancer	5.83e-05	0.000413	CcSEcCtD
Dasatinib—Fatigue—Methotrexate—germ cell cancer	5.82e-05	0.000412	CcSEcCtD
Dasatinib—Pain—Methotrexate—germ cell cancer	5.77e-05	0.000409	CcSEcCtD
Dasatinib—ABCG2—midbrain—germ cell cancer	5.76e-05	0.000404	CbGeAlD
Dasatinib—ABL1—brain—germ cell cancer	5.74e-05	0.000402	CbGeAlD
Dasatinib—ABCG2—bone marrow—germ cell cancer	5.64e-05	0.000396	CbGeAlD
Dasatinib—ABCG2—spinal cord—germ cell cancer	5.62e-05	0.000394	CbGeAlD
Dasatinib—Feeling abnormal—Methotrexate—germ cell cancer	5.56e-05	0.000394	CcSEcCtD
Dasatinib—ABL1—lymph node—germ cell cancer	5.55e-05	0.000389	CbGeAlD
Dasatinib—Gastrointestinal pain—Methotrexate—germ cell cancer	5.52e-05	0.000391	CcSEcCtD
Dasatinib—ABCG2—female gonad—germ cell cancer	5.44e-05	0.000381	CbGeAlD
Dasatinib—Urticaria—Methotrexate—germ cell cancer	5.36e-05	0.00038	CcSEcCtD
Dasatinib—Body temperature increased—Methotrexate—germ cell cancer	5.34e-05	0.000378	CcSEcCtD
Dasatinib—Abdominal pain—Methotrexate—germ cell cancer	5.34e-05	0.000378	CcSEcCtD
Dasatinib—CYP1A1—female gonad—germ cell cancer	5.16e-05	0.000362	CbGeAlD
Dasatinib—CYP3A5—female gonad—germ cell cancer	5.05e-05	0.000354	CbGeAlD
Dasatinib—ABCB1—trigeminal ganglion—germ cell cancer	5.04e-05	0.000353	CbGeAlD
Dasatinib—Hypersensitivity—Methotrexate—germ cell cancer	4.97e-05	0.000352	CcSEcCtD
Dasatinib—CYP1A2—endocrine gland—germ cell cancer	4.87e-05	0.000341	CbGeAlD
Dasatinib—ABCB1—embryo—germ cell cancer	4.86e-05	0.000341	CbGeAlD
Dasatinib—CYP1B1—brain—germ cell cancer	4.86e-05	0.000341	CbGeAlD
Dasatinib—Asthenia—Methotrexate—germ cell cancer	4.84e-05	0.000343	CcSEcCtD
Dasatinib—ABCG2—testis—germ cell cancer	4.83e-05	0.000338	CbGeAlD
Dasatinib—CYP1A1—endocrine gland—germ cell cancer	4.8e-05	0.000337	CbGeAlD
Dasatinib—Pruritus—Methotrexate—germ cell cancer	4.78e-05	0.000338	CcSEcCtD
Dasatinib—CYP1A1—head—germ cell cancer	4.74e-05	0.000332	CbGeAlD
Dasatinib—CYP1B1—lymph node—germ cell cancer	4.7e-05	0.000329	CbGeAlD
Dasatinib—CYP3A5—endocrine gland—germ cell cancer	4.7e-05	0.000329	CbGeAlD
Dasatinib—Diarrhoea—Methotrexate—germ cell cancer	4.62e-05	0.000327	CcSEcCtD
Dasatinib—Dizziness—Methotrexate—germ cell cancer	4.46e-05	0.000316	CcSEcCtD
Dasatinib—ABCG2—cerebellum—germ cell cancer	4.46e-05	0.000312	CbGeAlD
Dasatinib—ABCB1—retina—germ cell cancer	4.3e-05	0.000301	CbGeAlD
Dasatinib—Vomiting—Methotrexate—germ cell cancer	4.29e-05	0.000304	CcSEcCtD
Dasatinib—Rash—Methotrexate—germ cell cancer	4.26e-05	0.000302	CcSEcCtD
Dasatinib—Dermatitis—Methotrexate—germ cell cancer	4.25e-05	0.000301	CcSEcCtD
Dasatinib—Headache—Methotrexate—germ cell cancer	4.23e-05	0.0003	CcSEcCtD
Dasatinib—Nausea—Methotrexate—germ cell cancer	4.01e-05	0.000284	CcSEcCtD
Dasatinib—ABCB1—telencephalon—germ cell cancer	3.96e-05	0.000277	CbGeAlD
Dasatinib—ABCB1—decidua—germ cell cancer	3.75e-05	0.000263	CbGeAlD
Dasatinib—ABCG2—brain—germ cell cancer	3.62e-05	0.000254	CbGeAlD
Dasatinib—CYP3A4—endocrine gland—germ cell cancer	3.52e-05	0.000247	CbGeAlD
Dasatinib—ABCG2—lymph node—germ cell cancer	3.5e-05	0.000245	CbGeAlD
Dasatinib—CYP1A1—brain—germ cell cancer	3.44e-05	0.000241	CbGeAlD
Dasatinib—CYP1A1—lymph node—germ cell cancer	3.32e-05	0.000233	CbGeAlD
Dasatinib—ABCB1—gonad—germ cell cancer	3.3e-05	0.000231	CbGeAlD
Dasatinib—ABCB1—uterus—germ cell cancer	3.28e-05	0.00023	CbGeAlD
Dasatinib—ABCB1—pituitary gland—germ cell cancer	3.22e-05	0.000226	CbGeAlD
Dasatinib—ABCB1—medulla oblongata—germ cell cancer	3.11e-05	0.000218	CbGeAlD
Dasatinib—ABCB1—adrenal gland—germ cell cancer	2.88e-05	0.000202	CbGeAlD
Dasatinib—ABCB1—midbrain—germ cell cancer	2.84e-05	0.000199	CbGeAlD
Dasatinib—ABCB1—bone marrow—germ cell cancer	2.78e-05	0.000195	CbGeAlD
Dasatinib—ABCB1—spinal cord—germ cell cancer	2.77e-05	0.000194	CbGeAlD
Dasatinib—ABCB1—female gonad—germ cell cancer	2.68e-05	0.000188	CbGeAlD
Dasatinib—ABCB1—endocrine gland—germ cell cancer	2.5e-05	0.000175	CbGeAlD
Dasatinib—ABCB1—head—germ cell cancer	2.46e-05	0.000173	CbGeAlD
Dasatinib—ABCB1—testis—germ cell cancer	2.38e-05	0.000167	CbGeAlD
Dasatinib—ABCB1—cerebellum—germ cell cancer	2.2e-05	0.000154	CbGeAlD
Dasatinib—ABCB1—brain—germ cell cancer	1.78e-05	0.000125	CbGeAlD
Dasatinib—ABCB1—lymph node—germ cell cancer	1.72e-05	0.000121	CbGeAlD
Dasatinib—SRC—Disease—FGF4—germ cell cancer	8.44e-06	5.9e-05	CbGpPWpGaD
Dasatinib—BLK—Adaptive Immune System—HRAS—germ cell cancer	8.39e-06	5.86e-05	CbGpPWpGaD
Dasatinib—STAT5B—Disease—MYC—germ cell cancer	8.33e-06	5.82e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—FGF4—germ cell cancer	8.32e-06	5.81e-05	CbGpPWpGaD
Dasatinib—LYN—Axon guidance—HRAS—germ cell cancer	8.32e-06	5.81e-05	CbGpPWpGaD
Dasatinib—ABL1—Axon guidance—HRAS—germ cell cancer	8.28e-06	5.78e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—H2AFZ—germ cell cancer	8.25e-06	5.76e-05	CbGpPWpGaD
Dasatinib—FYN—Axon guidance—HRAS—germ cell cancer	8.19e-06	5.72e-05	CbGpPWpGaD
Dasatinib—YES1—Hemostasis—TP53—germ cell cancer	8.17e-06	5.7e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—FGF4—germ cell cancer	8.15e-06	5.69e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—FGFR3—germ cell cancer	8.06e-06	5.63e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—FGF4—germ cell cancer	8.02e-06	5.6e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—KITLG—germ cell cancer	8.02e-06	5.6e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—KIT—germ cell cancer	8.01e-06	5.59e-05	CbGpPWpGaD
Dasatinib—ERBB3—Innate Immune System—HRAS—germ cell cancer	8.01e-06	5.59e-05	CbGpPWpGaD
Dasatinib—YES1—Developmental Biology—HRAS—germ cell cancer	7.96e-06	5.56e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—KIT—germ cell cancer	7.92e-06	5.53e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—FGFR3—germ cell cancer	7.89e-06	5.51e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—FGFR3—germ cell cancer	7.86e-06	5.49e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—AVP—germ cell cancer	7.84e-06	5.47e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—KITLG—germ cell cancer	7.84e-06	5.47e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—OXT—germ cell cancer	7.83e-06	5.46e-05	CbGpPWpGaD
Dasatinib—YES1—Hemostasis—HRAS—germ cell cancer	7.81e-06	5.45e-05	CbGpPWpGaD
Dasatinib—JAK2—Axon guidance—HRAS—germ cell cancer	7.78e-06	5.44e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—CRABP1—germ cell cancer	7.75e-06	5.41e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—FGF4—germ cell cancer	7.73e-06	5.39e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—FGFR3—germ cell cancer	7.7e-06	5.37e-05	CbGpPWpGaD
Dasatinib—ERBB3—Adaptive Immune System—HRAS—germ cell cancer	7.69e-06	5.37e-05	CbGpPWpGaD
Dasatinib—LCK—Cytokine Signaling in Immune system—HRAS—germ cell cancer	7.66e-06	5.35e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—FGFR3—germ cell cancer	7.66e-06	5.35e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—FGF4—germ cell cancer	7.63e-06	5.33e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—FGFR3—germ cell cancer	7.6e-06	5.31e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—KITLG—germ cell cancer	7.59e-06	5.3e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—FGFR3—germ cell cancer	7.58e-06	5.29e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—H2AFZ—germ cell cancer	7.54e-06	5.27e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling by NGF—HRAS—germ cell cancer	7.53e-06	5.26e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—KITLG—germ cell cancer	7.51e-06	5.25e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—H2AFZ—germ cell cancer	7.43e-06	5.19e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—AVP—germ cell cancer	7.42e-06	5.18e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—KIT—germ cell cancer	7.4e-06	5.16e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—CRABP1—germ cell cancer	7.32e-06	5.11e-05	CbGpPWpGaD
Dasatinib—CSK—Immune System—HRAS—germ cell cancer	7.32e-06	5.11e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—FGFR3—germ cell cancer	7.3e-06	5.09e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—SLC2A3—germ cell cancer	7.28e-06	5.09e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—H2AFZ—germ cell cancer	7.28e-06	5.08e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—FGFR3—germ cell cancer	7.26e-06	5.07e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—KIT—germ cell cancer	7.24e-06	5.06e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—KIT—germ cell cancer	7.22e-06	5.04e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—FGFR3—germ cell cancer	7.2e-06	5.03e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—SLC22A3—germ cell cancer	7.18e-06	5.01e-05	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	7.17e-06	5.01e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—H2AFZ—germ cell cancer	7.16e-06	5e-05	CbGpPWpGaD
Dasatinib—STAT5B—Immune System—HRAS—germ cell cancer	7.09e-06	4.95e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—KIT—germ cell cancer	7.07e-06	4.93e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—KIT—germ cell cancer	7.03e-06	4.91e-05	CbGpPWpGaD
Dasatinib—YES1—Innate Immune System—HRAS—germ cell cancer	7.03e-06	4.91e-05	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—TP53—germ cell cancer	7.02e-06	4.9e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—FGFR3—germ cell cancer	7e-06	4.89e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—KIT—germ cell cancer	6.98e-06	4.87e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—KIT—germ cell cancer	6.96e-06	4.86e-05	CbGpPWpGaD
Dasatinib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	6.94e-06	4.85e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—KITLG—germ cell cancer	6.94e-06	4.84e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—OXT—germ cell cancer	6.93e-06	4.84e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—H2AFZ—germ cell cancer	6.9e-06	4.82e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—KITLG—germ cell cancer	6.84e-06	4.78e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—H2AFZ—germ cell cancer	6.81e-06	4.76e-05	CbGpPWpGaD
Dasatinib—CSK—Disease—HRAS—germ cell cancer	6.76e-06	4.72e-05	CbGpPWpGaD
Dasatinib—YES1—Adaptive Immune System—HRAS—germ cell cancer	6.75e-06	4.72e-05	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—HRAS—germ cell cancer	6.72e-06	4.69e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—KIT—germ cell cancer	6.7e-06	4.68e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—KITLG—germ cell cancer	6.69e-06	4.68e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—AVP—germ cell cancer	6.68e-06	4.67e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—FGF4—germ cell cancer	6.68e-06	4.66e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—FGFR3—germ cell cancer	6.67e-06	4.66e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling by NGF—HRAS—germ cell cancer	6.67e-06	4.66e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—KIT—germ cell cancer	6.66e-06	4.65e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—FGFR3—germ cell cancer	6.65e-06	4.64e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—KIT—germ cell cancer	6.61e-06	4.62e-05	CbGpPWpGaD
Dasatinib—HCK—Disease—MYC—germ cell cancer	6.6e-06	4.61e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—KITLG—germ cell cancer	6.59e-06	4.6e-05	CbGpPWpGaD
Dasatinib—STAT5B—Disease—HRAS—germ cell cancer	6.54e-06	4.57e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—AVP—germ cell cancer	6.54e-06	4.57e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—AVP—germ cell cancer	6.44e-06	4.5e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—KIT—germ cell cancer	6.42e-06	4.49e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—KITLG—germ cell cancer	6.35e-06	4.43e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—FGFR3—germ cell cancer	6.31e-06	4.41e-05	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—HRAS—germ cell cancer	6.29e-06	4.4e-05	CbGpPWpGaD
Dasatinib—KIT—Innate Immune System—HRAS—germ cell cancer	6.28e-06	4.38e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—KITLG—germ cell cancer	6.27e-06	4.38e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—AVP—germ cell cancer	6.2e-06	4.33e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—KIT—germ cell cancer	6.13e-06	4.28e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—AVP—germ cell cancer	6.12e-06	4.28e-05	CbGpPWpGaD
Dasatinib—BTK—Immune System—HRAS—germ cell cancer	6.12e-06	4.28e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—KIT—germ cell cancer	6.1e-06	4.26e-05	CbGpPWpGaD
Dasatinib—LYN—Hemostasis—TP53—germ cell cancer	6.09e-06	4.25e-05	CbGpPWpGaD
Dasatinib—ABL1—Hemostasis—TP53—germ cell cancer	6.06e-06	4.23e-05	CbGpPWpGaD
Dasatinib—SRC—Axon guidance—HRAS—germ cell cancer	6.04e-06	4.22e-05	CbGpPWpGaD
Dasatinib—KIT—Adaptive Immune System—HRAS—germ cell cancer	6.03e-06	4.21e-05	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—MYC—germ cell cancer	6.03e-06	4.21e-05	CbGpPWpGaD
Dasatinib—FYN—Hemostasis—TP53—germ cell cancer	5.99e-06	4.19e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—H2AFZ—germ cell cancer	5.96e-06	4.17e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—FGFR3—germ cell cancer	5.96e-06	4.16e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Innate Immune System—HRAS—germ cell cancer	5.94e-06	4.15e-05	CbGpPWpGaD
Dasatinib—LYN—Developmental Biology—HRAS—germ cell cancer	5.94e-06	4.15e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—FGF4—germ cell cancer	5.91e-06	4.13e-05	CbGpPWpGaD
Dasatinib—ABL1—Developmental Biology—HRAS—germ cell cancer	5.91e-06	4.13e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CRABP1—germ cell cancer	5.85e-06	4.08e-05	CbGpPWpGaD
Dasatinib—FYN—Developmental Biology—HRAS—germ cell cancer	5.84e-06	4.08e-05	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—MYC—germ cell cancer	5.84e-06	4.08e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—FGFR3—germ cell cancer	5.82e-06	4.07e-05	CbGpPWpGaD
Dasatinib—LYN—Hemostasis—HRAS—germ cell cancer	5.82e-06	4.07e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—SLC2A3—germ cell cancer	5.82e-06	4.06e-05	CbGpPWpGaD
Dasatinib—ABL1—Hemostasis—HRAS—germ cell cancer	5.8e-06	4.05e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—KIT—germ cell cancer	5.79e-06	4.04e-05	CbGpPWpGaD
Dasatinib—MAPK14—Hemostasis—TP53—germ cell cancer	5.77e-06	4.03e-05	CbGpPWpGaD
Dasatinib—FYN—Hemostasis—HRAS—germ cell cancer	5.73e-06	4e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—SLC22A3—germ cell cancer	5.73e-06	4e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Adaptive Immune System—HRAS—germ cell cancer	5.71e-06	3.99e-05	CbGpPWpGaD
Dasatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	5.7e-06	3.98e-05	CbGpPWpGaD
Dasatinib—JAK2—Hemostasis—TP53—germ cell cancer	5.7e-06	3.98e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—FGFR3—germ cell cancer	5.64e-06	3.94e-05	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—HRAS—germ cell cancer	5.63e-06	3.93e-05	CbGpPWpGaD
Dasatinib—HCK—Immune System—HRAS—germ cell cancer	5.62e-06	3.92e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—FGFR3—germ cell cancer	5.58e-06	3.9e-05	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—HRAS—germ cell cancer	5.56e-06	3.88e-05	CbGpPWpGaD
Dasatinib—MAPK14—Hemostasis—HRAS—germ cell cancer	5.52e-06	3.86e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—KITLG—germ cell cancer	5.49e-06	3.83e-05	CbGpPWpGaD
Dasatinib—ERBB3—Disease—MYC—germ cell cancer	5.48e-06	3.83e-05	CbGpPWpGaD
Dasatinib—JAK2—Hemostasis—HRAS—germ cell cancer	5.45e-06	3.81e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—AVP—germ cell cancer	5.36e-06	3.75e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Innate Immune System—HRAS—germ cell cancer	5.35e-06	3.74e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—KIT—germ cell cancer	5.35e-06	3.73e-05	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—HRAS—germ cell cancer	5.29e-06	3.7e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—H2AFZ—germ cell cancer	5.28e-06	3.69e-05	CbGpPWpGaD
Dasatinib—LYN—Innate Immune System—HRAS—germ cell cancer	5.24e-06	3.66e-05	CbGpPWpGaD
Dasatinib—ABL1—Innate Immune System—HRAS—germ cell cancer	5.22e-06	3.64e-05	CbGpPWpGaD
Dasatinib—HCK—Disease—HRAS—germ cell cancer	5.19e-06	3.62e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—KIT—germ cell cancer	5.18e-06	3.62e-05	CbGpPWpGaD
Dasatinib—FYN—Innate Immune System—HRAS—germ cell cancer	5.16e-06	3.6e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—FGFR3—germ cell cancer	5.16e-06	3.6e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Adaptive Immune System—HRAS—germ cell cancer	5.14e-06	3.59e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—KIT—germ cell cancer	5.13e-06	3.58e-05	CbGpPWpGaD
Dasatinib—BLK—Immune System—HRAS—germ cell cancer	5.09e-06	3.55e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—FGFR3—germ cell cancer	5.08e-06	3.55e-05	CbGpPWpGaD
Dasatinib—FGR—Immune System—HRAS—germ cell cancer	5.07e-06	3.54e-05	CbGpPWpGaD
Dasatinib—LYN—Adaptive Immune System—HRAS—germ cell cancer	5.03e-06	3.52e-05	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—TP53—germ cell cancer	4.99e-06	3.49e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—FGFR3—germ cell cancer	4.98e-06	3.47e-05	CbGpPWpGaD
Dasatinib—MAPK14—Innate Immune System—HRAS—germ cell cancer	4.97e-06	3.47e-05	CbGpPWpGaD
Dasatinib—FYN—Adaptive Immune System—HRAS—germ cell cancer	4.96e-06	3.46e-05	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—TP53—germ cell cancer	4.95e-06	3.46e-05	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—HRAS—germ cell cancer	4.91e-06	3.43e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—FGFR3—germ cell cancer	4.9e-06	3.42e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—KITLG—germ cell cancer	4.86e-06	3.39e-05	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—TP53—germ cell cancer	4.79e-06	3.35e-05	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—HRAS—germ cell cancer	4.77e-06	3.33e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—AVP—germ cell cancer	4.75e-06	3.32e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—KIT—germ cell cancer	4.73e-06	3.31e-05	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—HRAS—germ cell cancer	4.73e-06	3.3e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—FGFR3—germ cell cancer	4.72e-06	3.29e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CRABP1—germ cell cancer	4.67e-06	3.26e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—KIT—germ cell cancer	4.67e-06	3.26e-05	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—HRAS—germ cell cancer	4.67e-06	3.26e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—FGFR3—germ cell cancer	4.66e-06	3.25e-05	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—HRAS—germ cell cancer	4.58e-06	3.2e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—KIT—germ cell cancer	4.57e-06	3.19e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—KIT—germ cell cancer	4.5e-06	3.14e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—SLC2A3—germ cell cancer	4.49e-06	3.13e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—SLC22A3—germ cell cancer	4.42e-06	3.09e-05	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—TP53—germ cell cancer	4.42e-06	3.09e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—MYC—germ cell cancer	4.36e-06	3.04e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—KIT—germ cell cancer	4.33e-06	3.02e-05	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—HRAS—germ cell cancer	4.31e-06	3.01e-05	CbGpPWpGaD
Dasatinib—ERBB3—Disease—HRAS—germ cell cancer	4.31e-06	3.01e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—MYC—germ cell cancer	4.3e-06	3e-05	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—HRAS—germ cell cancer	4.3e-06	3e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—KIT—germ cell cancer	4.28e-06	2.99e-05	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—HRAS—germ cell cancer	4.23e-06	2.95e-05	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—HRAS—germ cell cancer	4.13e-06	2.88e-05	CbGpPWpGaD
Dasatinib—YES1—Immune System—HRAS—germ cell cancer	4.1e-06	2.86e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—FGFR3—germ cell cancer	4.08e-06	2.85e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—MYC—germ cell cancer	4.07e-06	2.84e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—MYC—germ cell cancer	3.98e-06	2.78e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—MYC—germ cell cancer	3.84e-06	2.68e-05	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—HRAS—germ cell cancer	3.8e-06	2.66e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—KIT—germ cell cancer	3.74e-06	2.61e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—MYC—germ cell cancer	3.67e-06	2.56e-05	CbGpPWpGaD
Dasatinib—MAPK14—Gene Expression—MYC—germ cell cancer	3.66e-06	2.56e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—HRAS—germ cell cancer	3.66e-06	2.55e-05	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—HRAS—germ cell cancer	3.65e-06	2.55e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—FGFR3—germ cell cancer	3.61e-06	2.52e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CRABP1—germ cell cancer	3.6e-06	2.52e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—TP53—germ cell cancer	3.58e-06	2.5e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—MYC—germ cell cancer	3.53e-06	2.47e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—HRAS—germ cell cancer	3.46e-06	2.42e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—HRAS—germ cell cancer	3.42e-06	2.39e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—HRAS—germ cell cancer	3.38e-06	2.36e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—MYC—germ cell cancer	3.37e-06	2.35e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—MYC—germ cell cancer	3.36e-06	2.35e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—KIT—germ cell cancer	3.31e-06	2.31e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—TP53—germ cell cancer	3.27e-06	2.29e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—HRAS—germ cell cancer	3.2e-06	2.23e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—TP53—germ cell cancer	3.15e-06	2.2e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—HRAS—germ cell cancer	3.13e-06	2.19e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—HRAS—germ cell cancer	3.13e-06	2.18e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—HRAS—germ cell cancer	3.12e-06	2.18e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—HRAS—germ cell cancer	3.05e-06	2.13e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—HRAS—germ cell cancer	3.04e-06	2.12e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—HRAS—germ cell cancer	3.02e-06	2.11e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MYC—germ cell cancer	3.01e-06	2.1e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—HRAS—germ cell cancer	3.01e-06	2.1e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—MYC—germ cell cancer	2.94e-06	2.05e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—HRAS—germ cell cancer	2.89e-06	2.02e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—HRAS—germ cell cancer	2.88e-06	2.01e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—HRAS—germ cell cancer	2.86e-06	2e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MYC—germ cell cancer	2.85e-06	1.99e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—HRAS—germ cell cancer	2.78e-06	1.94e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—TP53—germ cell cancer	2.77e-06	1.93e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—HRAS—germ cell cancer	2.65e-06	1.85e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—HRAS—germ cell cancer	2.64e-06	1.84e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—MYC—germ cell cancer	2.6e-06	1.82e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MYC—germ cell cancer	2.57e-06	1.79e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MYC—germ cell cancer	2.51e-06	1.76e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—HRAS—germ cell cancer	2.5e-06	1.75e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MYC—germ cell cancer	2.47e-06	1.73e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TP53—germ cell cancer	2.47e-06	1.73e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MYC—germ cell cancer	2.38e-06	1.66e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—HRAS—germ cell cancer	2.36e-06	1.65e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MYC—germ cell cancer	2.35e-06	1.64e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TP53—germ cell cancer	2.34e-06	1.63e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—HRAS—germ cell cancer	2.31e-06	1.61e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—HRAS—germ cell cancer	2.24e-06	1.56e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—HRAS—germ cell cancer	2.22e-06	1.55e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TP53—germ cell cancer	2.11e-06	1.47e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TP53—germ cell cancer	2.06e-06	1.44e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MYC—germ cell cancer	2.06e-06	1.44e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—HRAS—germ cell cancer	2.05e-06	1.43e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TP53—germ cell cancer	2.03e-06	1.42e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—HRAS—germ cell cancer	2.02e-06	1.41e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—HRAS—germ cell cancer	1.97e-06	1.38e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TP53—germ cell cancer	1.96e-06	1.37e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—HRAS—germ cell cancer	1.94e-06	1.36e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TP53—germ cell cancer	1.93e-06	1.35e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—HRAS—germ cell cancer	1.87e-06	1.31e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—HRAS—germ cell cancer	1.85e-06	1.29e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MYC—germ cell cancer	1.82e-06	1.27e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TP53—germ cell cancer	1.69e-06	1.18e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—HRAS—germ cell cancer	1.62e-06	1.13e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TP53—germ cell cancer	1.5e-06	1.05e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—HRAS—germ cell cancer	1.43e-06	1e-05	CbGpPWpGaD
